Government of India has finally given permission to conduct trials in prevention and treatment of COVID 19 using homeopathy medicines. Only very rare homeopaths who have access to institutions with facilities for quatentine and covid management will be able to utilize this opportunity. Since I have no such access, I am unfortunately compelled to stay back.
Those homeopaths who are fortunate to conduct trials, should be very careful. You will have to do this trial in a very inimical environment. There will be ethical committees, monitoring committees, evaluation committees etc in such institutions to oversee your work, which will be constituted by modern medical doctors mostly determined to prove homeopathy ineffective. All the paramedical staff and resident doctors will not be under your control. You can imagine what would be the outcome in such situations.
Remember, you are bound to fail, if you think you can convince the skeptics regarding the efficacy of potentized homeopathic drugs by conducting conventional types of ‘clinical trials’ or RCTs as they demand for.
You can never expect ‘individual-based’ homeopathic drugs to be proved using the protocols of testing drugs in ‘disease-based’ modern medicine. Asking to ‘prove’ homeopathic drugs using protocols of allopathic drug trials is like trying to measure ‘length’ using units of ‘mass’.
Allopathic methods of ‘drug trials’ are applicable to ‘molecular forms’ of drugs only. But potentized homeopathic drugs, different from allopathic drugs, contain only ‘molecular imprints’, which can act only up on pathogenic molecules having specific conformational affinity. That means, potentized drugs can act only if indicated by similarity of symptoms.
You cannot ignore this peculiarity of homeopathy in matters of active principles as well as mechanism of drug actions while designing ‘drug trials’ for homeopathy.
In homeopathy, you cannot ‘verify’ action of a particular drug on a particular disease- you have to ‘verify’ action of ‘indicated drugs’ up on indicated individual patients, since different people with same disease may need different drugs.
Same time, disease-specific combinations of post-avogadro dilutions could be subjected to Random Controlled Trials in the same way as allopathic drugs. This is the most effective way to prove that potentized homeopathy drugs are not placebo, fraud, or “mere water”, but they really work.
As far as skeptics as well as homeopaths hesitate to accept this peculiarity of potentized homeopathic drugs and agree to design the ‘trials’ of disease-specific combinations of post-avogadro dilutions, there is no way to convince the scientists that ‘homeopathy’ works’.
I would suggest you to prepare your own combinations for Covid-19 trial, incorporating ALL the drugs you think indicated for that disease, and conduct trials using that combination.
COVID 19 trials pose both an opportunity and a challenge for homeopathy. If we fail in this challenge – remember, people around you want you to fail- it will be very difficult for us to come back.
Ensure success for homeopathy in this trial. Cast away your theoretical prejudices. Don’t hesitate to use multiple remedies and combinations. Don’t hesitate to repeat doses in enough quantities and frequencies. Use 30c potencies only to ensure perfect result.
I WANT TO REPEAT: WE CAN SUCCESSFULLY PROVE THE EFFECTIVENESS OF HOMEOPATHY THROUGH RANDOM CONTROLLED TRIALS ONLY BY USING DISEASE-SPECIFIC COMBINATIONS OF POST-AVOGADRO DILUTIONS.
This is an earnest appeal from an old man who has been loving, living, learning, experimenting and researching homeopathy for around last FIFTY YEARS!
One thought on “TO THOSE WHO CONDUCT HOMEOPATHIC DRUG TRIALS FOR COVID-19.”
It will be proved soon how this mystical medicine works.
Germany DHU Pharmaceutical is already recording traits of medicinal plants from decade as they produce large amount of medicines.
Their data can be useful for helping man kind during this pandemic. I have visited DHU for training and have seen how they potentize Homeopathy medicine .i request our research team to gets in touch with them for clinical local data.